首页> 外国专利> RHEUMATOID ARTHRITIS DISEASE SENSITIVE GENE, ITS PROTEIN, METHOD AND KIT OF JUDGING THE ONSET OF RHEUMATOID ARTHRITIS USING THE SAME, AND METHOD AND DRUGS FOR TREATING RHEUMATOID ARTHRITIS

RHEUMATOID ARTHRITIS DISEASE SENSITIVE GENE, ITS PROTEIN, METHOD AND KIT OF JUDGING THE ONSET OF RHEUMATOID ARTHRITIS USING THE SAME, AND METHOD AND DRUGS FOR TREATING RHEUMATOID ARTHRITIS

机译:类风湿关节炎疾病的敏感基因,其蛋白质,使用该类判断类风湿关节炎发病的方法和试剂盒,治疗类风湿关节炎的方法和药物

摘要

A rheumatoid arthritis disease sensitivity gene (I) encoding Angiopoietin-1 protein having a fully defined sequence of 498 amino acids (S1), given in the specification which has a glycine insertion variation at position 269, is new. Independent claims are included for the following: (1) protein (II) consisting of (S1) and a glycine insertion variation at the 269 position of the sequence; (2) determining the onset of rheumatoid arthritis; (3) determining the onset of rheumatoid arthritis by detecting the presence or absence of (I) or (II), or by using determination kit; (4) treating rheumatoid arthritis; and (5) therapeutic drug used for treatment of rheumatoid arthritis in a patient who has (II). ACTIVITY : Antirheumatic; Antiarthritic. No biological data is given. MECHANISM OF ACTION : Angiopoietin-1 protein agonist; Gene therapy.
机译:新的编码类风湿关节炎疾病敏感性基因(I),其编码具有在498位氨基酸处有甘氨酸插入变异的完整定义的498个氨基酸序列(S1)的血管生成素-1蛋白。包括以下方面的独立权利要求:(1)由(S1)组成的蛋白质(II)和在序列269位的甘氨酸插入变异。 (2)确定类风湿关节炎的发作; (3)通过检测(I)或(II)的存在或不存在或使用测定试剂盒来确定类风湿关节炎的发作; (4)治疗类风湿关节炎; (5)用于患有(II)的患者的类风湿性关节炎的治疗药。活动:抗风湿;抗关节炎。没有给出生物学数据。作用机理:Angiopoietin-1蛋白激动剂。基因治疗。

著录项

  • 公开/公告号EP1471143A4

    专利类型

  • 公开/公告日2005-09-14

    原文格式PDF

  • 申请/专利权人 SHIOZAWA SHUNICHI;

    申请/专利号EP20030700501

  • 申请日2003-01-08

  • 分类号C07K14/515;C12Q1/68;A61K45/00;A61K38/17;A61K48/00;

  • 国家 EP

  • 入库时间 2022-08-21 22:08:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号